| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.08 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.08 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |